Luis Diaz
4Patents
1h-index
13Co-inventors
41Inventor score
Filing activity: Dec 2, 2005 → Mar 30, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10563266B2 | Neoantigen treatment prioritization using multivariate analysis based on: HLA genotype, self-similarity, similarity to known antigens, antigen expression levels and mutant allele frequency | Physics | 2 | Active |
| US12331361B2 | Methods and systems for identification and prioritization of mutation-derived neoantigens | Physics | 0 | Active |
| US8008093B2 | Inhibition of Hsp27 phosphorylation for the treatment of blistering disorders | Human Necessities | 0 | Active |
| US12086985B2 | Methods and systems for predicting response to PD-1 axis directed therapeutics | Physics | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.